OTHERS

HDFC Bank partners with B2B pharma market place Retailio to launch co-branded credit cards, Aims to reach 1.4 lakh customers in initial phase

Mumbai, May 23, 2022 (GNI): HDFC Bank, India’s largest private sector bank and Retailio, India’s largest B2B pharma marketplace today announced the launch of a new range of co-branded credit cards. These B2B credit cards are…


No Picture

Karkinos Healthcare receives investment for development of innovative healthcare solutions, Investment with representation on Board of Directors, technical know-how transfer

Mumbai, 23 May 2022 (GNI): Karkinos Healthcare, a technology-driven, oncology focussed managed health care platform, today announced that Mayo Clinic has invested a minority stake in the company, subject to certain conditions precedent. Mayo Clinic…


Artists and celebs throng NGMA retrospective tribute to Rini Dhumal and her colourful canvas of life…

Video Footages & Bytes https://we.tl/t-bvOK4scj9S https://we.tl/t-pfHjigbWOG https://we.tl/t-tgOyxNCLz7 https://we.tl/t-evUtr3fqFU Mumbai, 21st May 2022 (GNI): Every artist dips his brush into his soul, and then emerges a masterpiece. This seems to be so true for artist Rini Dhumal….





No Picture

HDFC Bank carves out Rural Banking business to penetrate deeper into Bharat, Bank to open over 1,060 branches in semi-urban and rural areas this FY

_ _ _ Mumbai, May 19, 2022 (GNI): HDFC bank today announced it has carved out Rural Banking function to penetrate deeper into Bharat. Tasked to take banking products further in the hinterland, Rural Banking will…


No Picture

‘बॉम्ब डिस्पोजल स्क्वाड’ मधील पोलिसाला अपोलोने दिले जीवनदान, ४२ वर्षीय आशीर्वाद लाडगे जिलेटीन बॉम्ब न्यूट्रलाइज करताना स्फोटात गंभीर जखमी झाले होते

नवी मुंबई, १९ मे २०२२ (GNI): रायगड जिल्हा पोलीसच्या बॉम्ब डिटेक्शन अँड डिस्पोजल स्क्वाडमधील कर्मचारी श्री.आशीर्वाद लाडगे (वय वर्षे ४२) महाराष्ट्रातील रायगड जिल्ह्यातील महाड येथे पोलीस परिसरात एक जिलेटीन बॉम्ब न्यूट्रलाइज करण्याचा प्रयत्न करत असताना झालेल्या…


Regrow Biosciences gets USFDA Nod for Phase II trials of ‘OSSGROW’ for Osteonecrosis in the US~OSSGROW is India’s first FDA (DCGI) approved product that has treated over 1000 patients across 200 hospitals in the country

Mumbai, 19 May 2022 (GNI): Regrow Biosciences, an Indian-centric global biotech company, is glad to announce a breakthrough achievement of getting a USFDA nod for conducting a phase II trial of its lead  product ‘OSSGROW,’…